Subject to their eligibility and consent, we are aiming for every patient with COVID-19 disease who is admitted to our hospitals to be given the opportunity to be part of one of the research trials or studies that we are running at Imperial.
Summary of recruitment to our key studies:
|Study||Recruitment to date|
|Novel Coronavirus Observational Study (ISARIC)||Tier 0: 1364
Tier 2: 77
|Imperial Health Knowledge Bank||731|
|COVAC1 (Imperial Vaccine Study)||120|
Find out more about ongoing studies, including recruitment over time, by following links below.